---
layout: splash
title: 삼천당제약 (000250)
excerpt: 삼천당제약의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
- 고PER
- 고PBR
keywords: 삼천당제약, 000250
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 111,100 | <span style="color: tomato">29.9<small>%</small></span> | Q:제약 | 419.2 | 14.1 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 하메론, 아토로우 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2000년 10월 4일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 전인석 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.scd.co.kr](http://www.scd.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 03&#x2011;22 | | [투자판단관련주요경영사항              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240322901424){:target="_blank"} |
| 03&#x2011;20 | | [사업보고서 (2023.12)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240320001960){:target="_blank"} |
|  | | [감사보고서제출              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240320902456){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![000250](/stock/images/000250.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 111,100 | <span style="color: tomato">29.9<small>%</small></span> | <span style="color: tomato">28.4<small>%</small></span> | <span style="color: tomato">51.2<small>%</small></span> | <span style="color: tomato">56.9<small>%</small></span> | <span style="color: tomato">39.9<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">41.2<small>%</small></span> | 74.7<small>%</small> | 0.55 | -49.0<small>%</small> | -26.8<small>%</small> | -0.8 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 419.2 | 14.1 | - | 고PER, 고PBR |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/000250/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=000250){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A000250&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=000250){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/000250){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/000250/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![000250](/stock/images/000250_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 41.2<small>%</small> | 74.7<small>%</small> | 0.55 | -49.0<small>%</small> | -26.8<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 60.0<small>%</small> | 73.7<small>%</small> | 0.81 | -38.5<small>%</small> | -22.9<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 93.1<small>%</small> | 58.0<small>%</small> | 1.61 | -31.1<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -24.5<small>%</small> | 42.3<small>%</small> | -0.58 | -43.4<small>%</small> | -27.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 22.7<small>%</small> | 56.2<small>%</small> | 0.40 | -39.6<small>%</small> | -24.7<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -0.8<small>%</small> | 51.4<small>%</small> | -0.02 | -48.6<small>%</small> | -32.7<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -25.8<small>%</small> | 54.8<small>%</small> | -0.47 | -59.2<small>%</small> | -42.4<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 1.9<small>%</small> | 71.7<small>%</small> | 0.03 | -49.0<small>%</small> | -31.2<small>%</small> |
| MACD[^fn_tech_metric_macd] | 54.3<small>%</small> | 58.5<small>%</small> | 0.93 | -38.3<small>%</small> | -17.2<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![000250](/stock/images/000250_corr.png){: .align-center}

|       | [세방전지](/004490/) | [레인보우로보틱스](/277810/) | [키움증권](/039490/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [아모레퍼시픽](/090430/) | [CJ](/001040/) | [KCC](/002380/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![000250](/stock/images/000250_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}